(Bloomberg) -- Warren Buffett’s Berkshire Hathaway Inc. cut two of its payment bets -- holdings in Visa Inc. and Mastercard Inc. -- as it also pulled back on investments in pharmaceutical giants AbbVie Inc. and Bristol Myers-Squibb Co.
Most Read from Bloomberg
Amazon Sued Over Crashes by Drivers Rushing to Make Deliveries
What Designers of Video Game Cities Understand About Real Cities
Biden Plan Funds New Bridges That Locals May Not Want
Hong Kong's New Museum Tries to Please Art World — and Beijing
Berkshire reported a 30% decrease in AbbVie and a 16% cut to its Bristol-Myers Squibb investment during the third quarter, according to a filing released Monday. The company’s Visa and Mastercard holdings were cut 4.3% and 6% respectively.
Most Read from Bloomberg Businessweek
First Task for the Teamsters’ Next Boss: Take On UPS
Google Wants to Save the Planet With Satellite Images
One of the World’s Poorest Countries Found a Better Way to Do Stimulus
Generation Lockdown: Where Youth Unemployment Has Surged
Lordstown’s Auto Industry Is Coming Back. The Jobs? Not So Much
©2021 Bloomberg L.P.
